SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Molina Healthcare

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options

If you suffered losses in Molina and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

On July 7, 2025, before the market opened, Molina issued a press release announcing financial results for the second quarter of 2025. The release revealed second-quarter adjusted earnings of approximately $5.50 per share, which was "below its prior expectations" due to "medical cost pressures in all three lines of business."

Citing expectations that these pressures would "continue into the second half of the year," Molina cut its full-year 2025 adjusted earnings per share guidance by 10.2% at the midpoint, from "at least $24.50 per share" to a "range of $21.50 to $22.50 per share."

On this news, Molina’s stock price fell $6.97, or 2.9%, to close at $232.61 per share on July 7, 2025, on unusually heavy trading volume.

Then, on July 23, 2025, after the market closed, Molina issued a press release reporting its full financial results for the second quarter and further slashing its full-year 2025 earnings guidance. The release stated that GAAP net income was $4.75 per diluted share, an 8% decrease year-over-year.

The company announced it "now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share," representing another 13.6% cut at the midpoint from the guidance issued less than two weeks earlier. The company also cut its full-year 2025 GAAP net income guidance by 27% to $912 million, citing a "challenging medical cost trend environment" and "new information gained in the quarterly closing process."

On this news, Molina’s stock price fell $32.03, or 16.84%, to close at $158.22 per share on July 24, 2025, on unusually heavy trading volume.

To learn more about the Molina Healthcare, Inc. investigation, go to www.faruqilaw.com/MOH or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251106119754/en/